Amneal Pharmaceuticals (AMRX) Return on Capital Employed Growth (1y) (2019 - 2026)
Amneal Pharmaceuticals (AMRX) Return on Capital Employed Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 1,195.00 |
| 10 | Amneal Pharmaceuticals | 5.74 Bn | 5.74 Bn | 320.11 Mn | -17.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.00 |
| Dec 31, 2025 | 369.00 |
| Sep 30, 2025 | 565.00 |
| Jun 30, 2025 | 909.00 |
| Mar 31, 2025 | 924.00 |
| Dec 31, 2024 | 313.00 |
| Sep 30, 2024 | -334.00 |
| Jun 30, 2024 | -292.00 |
| Mar 31, 2024 | 545.00 |
| Dec 31, 2023 | 800.00 |
| Sep 30, 2023 | 1,574.00 |
| Jun 30, 2023 | 1,563.00 |
| Mar 31, 2023 | -262.00 |
| Dec 31, 2022 | -518.00 |
| Sep 30, 2022 | -941.00 |
| Jun 30, 2022 | -943.00 |
| Mar 31, 2022 | 86.00 |
| Dec 31, 2021 | 193.00 |
| Sep 30, 2021 | 344.00 |
| Jun 30, 2021 | 596.00 |